Skip to main content

Table 3 Lipid profiles of CAD cases and controls according to APOA1 -75 G/A polymorphisms

From: Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease

  CAD P value Controls P value
GG GA AA GG GA AA
TG (mg/dL) 187.1 ± 79.3 198.9 ± 92.5 175.5 ± 86.2 0.72 160.5 ± 57.3 176.1 ± 62.4 156.9 ± 59.8 0.68
TC (mg/dL) 192.4 ± 55.7 206.4 ± 59.4 203.3 ± 56.8 0.44 178.9 ± 48.7 194.8 ± 53.6 191.4 ± 50.2 0.39
HDL-C (mg/dL) 30.4 ± 10.6 36.8 ± 11.9 41.5 ± 12.7 <0.001 37.1 ± 12.0 41.2 ± 13.6 46.8 ± 14.5 <0.001
LDL-C (mg/dL) 124.6 ± 36.9 129.8 ± 40.1 126.7 ± 38.2 0.87 109.7 ± 30.5 118.4 ± 36.5 113.2 ± 33.7 0.69
VLDL-C (mg/dL) 37.4 ± 12.4 39.8 ± 19.7 35.1 ± 10.6 0.31 32.1 ± 17.6 35.2 ± 18.4 31.4 ± 16.2 0.42
ApoA1 (mg/dL) 114.5 ± 20.7 127.6 ± 22.5 138.9 ± 24.1 <0.001 124.4 ± 23.5 135.7 ± 24.3 144.7 ± 25.8 <0.001
ApoB (mg/dL) 86.7 ± 25.4 97.6 ± 29.5 90.7 ± 26.9 0.63 88.1 ± 25.8 93.6 ± 27.5 89.5 ± 26.7 0.74
  1. CAD, coronary artery disease; APOA1, apolipoprotein A1; OR, odds ratio; CI, confidence interval; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL-C, very-low-density lipoprotein cholesterol; Apo, apolipoprotein